ACTIVE

PHARDEN

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

132,3 k €

-16.8% YoY

Gross margin

609,3 k €

-8.8% YoY

Equity

284,9 k €

+25.2% YoY

Workforce

8,6 ETP

-6.5% YoY

What does PHARDEN do?

PHARDEN is a Public limited company incorporated in 1993. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bièvre. It employs on average 8,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0449.472.066

Incorporation

18/02/1993

Legal form

Public limited company

Registered office

Rue de Bouillon 17
5555 Bièvre · WallonieSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

8,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Contacts

1 public detail availableLog in to view

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	609,3 k €	-8.8%	668,1 k €	+12.1%	596 k €	+22.3%	487,2 k €	-5.1%	513,7 k €	+13.0%	454,4 k €	+4.8%	433,6 k €	-8.0%	471,5 k €	-2.7%	484,7 k €	-8.4%	529,3 k €	+11.9%	473 k €	+14.7%	412,4 k €	+7.3%	384,4 k €	+65.3%	232,5 k €	+5.3%	220,9 k €	+5.9%	208,6 k €	-20.6%	262,8 k €	+16.3%	226 k €	+41.7%	159,5 k €	+18.2%	134,9 k €
EBITDA	233 k €	-16.2%	278 k €	+26.3%	220,1 k €	+40.1%	157,1 k €	+43.6%	109,4 k €	+31.3%	83,3 k €	-15.6%	98,7 k €	-33.4%	148,2 k €	-35.5%	229,9 k €	-9.4%	253,8 k €	+9.2%	232,3 k €	-4.2%	242,5 k €	+22.2%	198,4 k €	+126%	87,8 k €	+16.0%	75,7 k €	+9.2%	69,4 k €	-46.7%	130,3 k €	+9.5%	119 k €	+64.1%	72,5 k €	+21.2%	59,8 k €
Operating result	177,4 k €	-21.2%	225,2 k €	+28.8%	174,8 k €	+39.8%	125 k €	+44.0%	86,8 k €	+48.4%	58,5 k €	+55.4%	37,7 k €	-55.7%	85 k €	-43.0%	149,3 k €	-15.6%	177 k €	+10.6%	160 k €	-16.6%	191,8 k €	+27.7%	150,1 k €	+259%	41,8 k €	+20.8%	34,6 k €	+33.4%	25,9 k €	-76.3%	109,2 k €	+18.4%	92,2 k €	+34.7%	68,5 k €	+46.1%	46,9 k €
Net result	132,3 k €	-16.8%	159 k €	+35.0%	117,8 k €	+31.3%	89,7 k €	+36.7%	65,6 k €	+193%	22,4 k €	+7370%	300,1 €	-99.4%	48,7 k €	-40.4%	81,7 k €	-26.4%	111 k €	+19.7%	92,7 k €	-15.7%	109,9 k €	+33.2%	82,5 k €	+433%	15,5 k €	+836%	-2,1 k €	-163%	3,3 k €	-94.7%	62,2 k €	-16.7%	74,7 k €	+9.1%	68,5 k €	+90.9%	35,9 k €
Balance sheet
Equity	284,9 k €	+25.2%	227,5 k €	+92.0%	118,5 k €	-52.7%	250,7 k €	+17.8%	212,8 k €	+44.6%	147,2 k €	-20.3%	184,7 k €	-24.4%	244,4 k €	-4.4%	255,7 k €	+9.3%	234 k €	+15.2%	203 k €	+19.2%	170,3 k €	+41.5%	120,4 k €	+23.0%	97,9 k €	-12.9%	112,4 k €	-1.8%	114,5 k €	-15.9%	136,1 k €	-14.3%	158,9 k €	-58.1%	379,3 k €	+22.0%	310,8 k €
Total assets	1,1 M €	+10.0%	1 M €	-12.3%	1,2 M €	+40.4%	845,9 k €	+4.3%	811,1 k €	-24.0%	1,1 M €	+11.0%	961,8 k €	+8.8%	884,1 k €	-4.1%	922,4 k €	-7.6%	998,4 k €	+4.8%	952,6 k €	+19.7%	795,6 k €	-2.1%	812,4 k €	+4.1%	780,4 k €	-8.5%	852,6 k €	-6.7%	913,9 k €	+28.5%	711,5 k €	-26.5%	967,9 k €	+62.8%	594,4 k €	+19.0%	499,6 k €
Cash	243,8 k €	+69.5%	143,9 k €	+40.3%	102,6 k €	-18.3%	125,5 k €	+274%	33,6 k €	-5.5%	35,5 k €	-59.2%	87 k €	+30.8%	66,5 k €	-13.1%	76,5 k €	-8.3%	83,5 k €	-38.5%	135,8 k €	+56.7%	86,6 k €	+17.5%	73,7 k €	+75.3%	42 k €	-69.7%	138,7 k €	-16.5%	166,2 k €	-13.3%	191,8 k €	-55.1%	427,7 k €	+49.5%	286,1 k €	+417%	55,3 k €
Debts	860,3 k €	+5.7%	813,7 k €	-23.9%	1,1 M €	+79.9%	594,5 k €	-0.6%	598,4 k €	-34.9%	919 k €	+18.4%	776,4 k €	+21.7%	638,3 k €	-4.0%	664,9 k €	-12.9%	763,3 k €	+2.0%	748,5 k €	+20.1%	623,1 k €	-9.8%	690,7 k €	+1.2%	682,4 k €	-7.6%	738,1 k €	-7.6%	798,6 k €	+38.8%	575,3 k €	-28.8%	808,3 k €	+278%	214,1 k €	+13.5%	188,7 k €
Other
Workforce	8,6 ETP	-6.5%	9,2 ETP	+2.2%	9,0 ETP	+7.1%	8,4 ETP	-17.6%	10,2 ETP	+5.2%	9,7 ETP	+11.5%	8,7 ETP	0.0%	8,7 ETP	+31.8%	6,6 ETP	-7.0%	7,1 ETP	+22.4%	5,8 ETP	+31.8%	4,4 ETP	+4.8%	4,2 ETP	+20.0%	3,5 ETP	+6.1%	3,3 ETP	+6.5%	3,1 ETP	0.0%	3,1 ETP	+10.7%	2,8 ETP	+21.7%	2,3 ETP	+27.8%	1,8 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 27 ended

Active mandates

CYRILLE REGNIER

Andere functie

Active

DR PHARMA

Director · 0778.778.554

Active

Ended mandates

DR PHARMA

Director · since 01 janvier 2022 · 0778.778.554

Represented by CYRILLE REGNIER

Ended

Benoît CLOSSON

Director · since 01 janvier 2020 · until 30 juin 2025

Ended

CLOSSON

Managing director · since 01 janvier 2020 · until 30 juin 2025 · 0842.494.785

Represented by Sylvie BRASSEUR

Ended

CLOSSON

Managing director · since 01 janvier 2020 · until 30 juin 2025 · 0842.494.785

Represented by Sylvie BRASSEUR

Ended

At this address

Other companies at this address

Company	CBE no.
Cabinet Médical Camille Dumonceaux● Active	0791.528.413
DR PHARMA● Active	0778.778.554

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	03/06/2026	02/06/2025	25/07/2024	30/08/2023	31/12/2022	16/07/2021
General meeting	29/05/2026	30/05/2025	31/05/2024	27/05/2023	17/10/2022	20/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/05/2026	03/06/2026	French	PDF
Abridged model	31/12/2024	30/05/2025	02/06/2025	French	PDF
Abridged model	31/12/2023	31/05/2024	25/07/2024	French	PDF
Abridged model	31/12/2022	27/05/2023	30/08/2023	French	PDF
Abridged model	31/12/2021	17/10/2022	31/12/2022	French	PDF
Abridged model	31/12/2020	20/06/2021	16/07/2021	French	PDF
Abridged model	31/12/2019	22/09/2020	21/10/2020	French	PDF
Abridged model	31/12/2018	28/06/2019	29/07/2019	French	PDF
Abridged model	31/12/2017	29/06/2018	12/07/2018	French	PDF
Abridged model	31/12/2016	26/09/2017	28/09/2017	French	PDF
Abridged model	31/12/2015	17/06/2016	27/07/2016	French	PDF
Abridged model	31/12/2014	25/06/2015	24/07/2015	French	PDF
Abridged model	31/12/2013	01/08/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	22/08/2013	30/08/2013	French	PDF
Abridged model	31/12/2011	29/06/2012	16/07/2012	French	PDF
Abridged model	31/12/2010	31/05/2011	10/06/2011	French	PDF
Abridged model	31/12/2009	14/06/2010	06/07/2010	French	PDF
Abridged model	31/12/2008	26/05/2009	02/07/2009	French	PDF
Abridged model	31/12/2007	27/05/2008	22/07/2008	French	PDF
Abridged model	31/12/2006	16/07/2007	31/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 27 ended

Active mandates

CYRILLE REGNIER

Andere functie

Active

DR PHARMA

Director · 0778.778.554

Active

Ended mandates

DR PHARMA

Director · since 01 janvier 2022 · 0778.778.554

Represented by CYRILLE REGNIER

Ended

Benoît CLOSSON

Director · since 01 janvier 2020 · until 30 juin 2025

Ended

CLOSSON

Managing director · since 01 janvier 2020 · until 30 juin 2025 · 0842.494.785

Represented by Sylvie BRASSEUR

Ended

CLOSSON

Managing director · since 01 janvier 2020 · until 30 juin 2025 · 0842.494.785

Represented by Sylvie BRASSEUR

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates30/06/2023
DEMISSIONS, NOMINATIONS
PDF
Other07/04/2022
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates26/01/2022
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates25/03/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates30/01/2014
DEMISSIONS, NOMINATIONS
PDF
Mandates15/02/2012
DEMISSIONS, NOMINATIONS
PDF
Mandates28/06/2010
DEMISSIONS, NOMINATIONS
PDF
Mandates21/01/2008
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025132,3 k €↓
2024
Annual accounts 2024159 k €↑
2023
Annual accounts 2023117,8 k €↑
2022
Annual accounts 202289,7 k €↑
2021
Annual accounts 202165,6 k €↑
2020
Annual accounts 202022,4 k €↑
2019
Annual accounts 2019300,1 €↓
2018
Annual accounts 201848,7 k €↓
2017
Annual accounts 201781,7 k €↓
2016
Annual accounts 2016111 k €↑
2015
Annual accounts 201592,7 k €↓
2014
Annual accounts 2014109,9 k €↑
2013
Annual accounts 201382,5 k €↑
2012
Annual accounts 201215,5 k €↑
2011
Annual accounts 2011-2,1 k €↓
2010
Annual accounts 20103,3 k €↓
2009
Annual accounts 200962,2 k €↓
2008
Annual accounts 200874,7 k €↑
2007
Annual accounts 200768,5 k €↑
2006
Annual accounts 200635,9 k €
18/02/1993
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARDEN

Overview

What does PHARDEN do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline